16th Annual Bud Suddath Symposium -Drug Design, Development & Delivery
March 7 - March 8, 2008

This year’s symposium focuses on making pharmaceuticals more effective, less expensive and more convenient for patients. The program features cutting-edge pharmaceutical research including the design and discovery of new drugs and vaccines, novel synthetic and biotechnological manufacturing methods, and advanced drug delivery systems.

The speakers include leading researchers, practitioners and policy makers from industry, academia and non-governmental organizations speaking about the design, development and delivery of small-molecule drugs, protein therapeutics and vaccines.

On behalf of the Co-Chairs, Mark Prausnitz and Andy Bommarius, the Parker H. Petit Institute for Bioengineering and Bioscience and the Center for Drug Design, Development and Delivery at the Georgia Institute of Technology, we look forward to welcoming you to Atlanta!

This symposium is held annually to celebrate the life and contributions of F.L. “Bud” Suddath by discussing the latest developments in the fields of bioengineering and bioscience. 

Plenary Speakers:

Barry Buckland, PhD - Vice President, Bioprocess R&D, Merck Research Laboratories

Dipika Matthias, MBA - Business Development Officer, PATH

Invited Speakers:

Dennis Choi, MD, PhD – Professor, Executive Director of  Strategic Neurosciences Initiative and Director of the Comprehensive Neuroscience Center in the Woodruff Health Sciences Center, Emory University

David Constable, PhD – Director and Team Leader, EHS Product Stewardship, Corporate Environment, Health and Safety GlaxoSmithKline

Jeroen Medema, MSc – Principal Scientist, Scientific Information Manager, Influenza, Solvay Biologicals LLC

Russ Middaugh, PhD – A. & T. Higuichi Distinguished Professor of Pharmaceutical Chemistry, University of Kansas

James K. Drennen, III , PhD – Associate Dean, Research and Graduate Programs, Mylan School of Pharmacy, Duquesne University

Eric Tomlinson, DSc, PhD – President and Chief Executive Officer, Altea Therapeutics 
 
Bruce Weniger, MD, MPH - Chief of Vaccine Technology, Immunization Safety Office, Centers for Disease Control and Prevention 

Jeff Ulmer, PhD - Head of External Research, Novartis Vaccines & Diagnostics

Binghe Wang, PhD – Professor, Medicinal Chemistry, Georgia Research Alliance Eminent Scholar in Drug Discovery, Georgia Cancer Coalition Distinguished Cancer Scientist, Georgia State University